# Gartner Inc: financial statements, quarterly

IT · NYSE · CIK 749251 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/it.md) · [Financials](/companies/it/financials.md) · [Filings](/companies/it/filings.md) · [Insiders](/companies/it/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/it/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,409](/filings/0000749251-24-000041.md) | [1,586 d](/filings/0000749251-26-000112.md) | [1,473](/filings/0000749251-25-000028.md) | [1,595](/filings/0000749251-25-000046.md) | [1,484](/filings/0000749251-25-000082.md) | [1,715 d](/filings/0000749251-26-000112.md) | [1,534](/filings/0000749251-26-000167.md) | [1,686](/filings/0000749251-26-000245.md) | [1,524](/filings/0000749251-25-000082.md) | [1,753 d](/filings/0000749251-26-000112.md) | [1,511](/filings/0000749251-26-000167.md) | [1,676](/filings/0000749251-26-000245.md) |
| Cost of revenue | $m | [451](/filings/0000749251-24-000041.md) | [530 d](/filings/0000749251-26-000112.md) | [459](/filings/0000749251-25-000028.md) | [513](/filings/0000749251-25-000046.md) | [475](/filings/0000749251-25-000082.md) | [575 d](/filings/0000749251-26-000112.md) | [475](/filings/0000749251-26-000167.md) | [532](/filings/0000749251-26-000245.md) | [474](/filings/0000749251-25-000082.md) | [573 d](/filings/0000749251-26-000112.md) | [429](/filings/0000749251-26-000167.md) | [487](/filings/0000749251-26-000245.md) |
| Gross profit | $m | not reported | not reported | [1,022](/filings/0000749251-25-000028.md) | [1,095](/filings/0000749251-25-000046.md) | [1,015](/filings/0000749251-25-000082.md) | [1,145 d](/filings/0000749251-26-000112.md) | [1,065](/filings/0000749251-26-000167.md) | [1,158](/filings/0000749251-26-000245.md) | [1,057](/filings/0000749251-25-000082.md) | [1,188 d](/filings/0000749251-26-000112.md) | [1,086](/filings/0000749251-26-000167.md) | [1,198](/filings/0000749251-26-000245.md) |
| Selling, general and administrative | $m | [661](/filings/0000749251-24-000041.md) | [704 d](/filings/0000749251-26-000112.md) | [690](/filings/0000749251-25-000028.md) | [712](/filings/0000749251-25-000046.md) | [712](/filings/0000749251-25-000082.md) | [771 d](/filings/0000749251-26-000112.md) | [730](/filings/0000749251-26-000167.md) | [777](/filings/0000749251-26-000245.md) | [763](/filings/0000749251-25-000082.md) | [798 d](/filings/0000749251-26-000112.md) | [726](/filings/0000749251-26-000167.md) | [765](/filings/0000749251-26-000245.md) |
| Operating income | $m | [244](/filings/0000749251-24-000041.md) | [301 d](/filings/0000749251-26-000112.md) | [274](/filings/0000749251-25-000028.md) | [319](/filings/0000749251-25-000046.md) | [246](/filings/0000749251-25-000082.md) | [318 d](/filings/0000749251-26-000112.md) | [278](/filings/0000749251-26-000167.md) | [327](/filings/0000749251-26-000245.md) | [86.3](/filings/0000749251-25-000082.md) | [334 d](/filings/0000749251-26-000112.md) | [316](/filings/0000749251-26-000167.md) | [379](/filings/0000749251-26-000245.md) |
| Interest expense | $m | [21.8](/filings/0000749251-23-000052.md) | [59.0 d](/filings/0000749251-24-000006.md) | [19.2](/filings/0000749251-24-000024.md) | [20.0](/filings/0000749251-25-000046.md) | [18.0](/filings/0000749251-25-000082.md) | [73.9 d](/filings/0000749251-26-000112.md) | [13.4](/filings/0000749251-26-000167.md) | [11.8](/filings/0000749251-26-000245.md) | [16.3](/filings/0000749251-25-000082.md) | [83.8 d](/filings/0000749251-26-000112.md) | [21.0](/filings/0000749251-26-000167.md) | [22.3](/filings/0000749251-26-000245.md) |
| Income tax | $m | [44.5](/filings/0000749251-24-000041.md) | [68.6 d](/filings/0000749251-26-000112.md) | [49.0](/filings/0000749251-25-000028.md) | [69.7](/filings/0000749251-25-000046.md) | [112](/filings/0000749251-25-000082.md) | [(96.9) d](/filings/0000749251-26-000112.md) | [56.1](/filings/0000749251-26-000167.md) | [77.0](/filings/0000749251-26-000245.md) | [34.1](/filings/0000749251-25-000082.md) | [71.7 d](/filings/0000749251-26-000112.md) | [70.1](/filings/0000749251-26-000167.md) | [79.1](/filings/0000749251-26-000245.md) |
| Net income | $m | [180](/filings/0000749251-24-000041.md) | [209 d](/filings/0000749251-26-000112.md) | [211](/filings/0000749251-25-000082.md) | [230](/filings/0000749251-25-000082.md) | [415](/filings/0000749251-25-000082.md) | [399 d](/filings/0000749251-26-000112.md) | [211](/filings/0000749251-26-000245.md) | [241](/filings/0000749251-26-000245.md) | [35.4](/filings/0000749251-25-000082.md) | [242 d](/filings/0000749251-26-000112.md) | [222](/filings/0000749251-26-000245.md) | [275](/filings/0000749251-26-000245.md) |
| Diluted EPS | $ per share | [2.26](/filings/0000749251-24-000041.md) | not reported | [2.67](/filings/0000749251-25-000028.md) | [2.93](/filings/0000749251-25-000046.md) | [5.32](/filings/0000749251-25-000082.md) | not reported | [2.71](/filings/0000749251-26-000167.md) | [3.11](/filings/0000749251-26-000245.md) | [0.47](/filings/0000749251-25-000082.md) | not reported | [3.18](/filings/0000749251-26-000167.md) | [4.14](/filings/0000749251-26-000245.md) |
| Basic EPS | $ per share | [2.28](/filings/0000749251-24-000041.md) | not reported | [2.69](/filings/0000749251-25-000028.md) | [2.95](/filings/0000749251-25-000046.md) | [5.36](/filings/0000749251-25-000082.md) | not reported | [2.73](/filings/0000749251-26-000167.md) | [3.12](/filings/0000749251-26-000245.md) | [0.47](/filings/0000749251-25-000082.md) | not reported | [3.19](/filings/0000749251-26-000167.md) | [4.14](/filings/0000749251-26-000245.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,249](/filings/0000749251-23-000052.md) | [1,319](/filings/0000749251-26-000112.md) | [1,236](/filings/0000749251-24-000024.md) | [1,236](/filings/0000749251-24-000035.md) | [1,768](/filings/0000749251-24-000041.md) | [1,933](/filings/0000749251-26-000112.md) | [2,091](/filings/0000749251-25-000028.md) | [2,198](/filings/0000749251-25-000046.md) | [1,431](/filings/0000749251-25-000082.md) | [1,723](/filings/0000749251-26-000245.md) | [1,667](/filings/0000749251-26-000167.md) | [1,489](/filings/0000749251-26-000245.md) |
| Current assets | $m | [2,838](/filings/0000749251-23-000052.md) | [3,428](/filings/0000749251-25-000008.md) | [3,326](/filings/0000749251-24-000024.md) | [3,109](/filings/0000749251-24-000035.md) | [3,552](/filings/0000749251-24-000041.md) | [4,197](/filings/0000749251-26-000112.md) | [4,132](/filings/0000749251-25-000028.md) | [3,974](/filings/0000749251-25-000046.md) | [3,063](/filings/0000749251-25-000082.md) | [4,066](/filings/0000749251-26-000245.md) | [3,648](/filings/0000749251-26-000167.md) | [3,224](/filings/0000749251-26-000245.md) |
| Total assets | $m | [7,244](/filings/0000749251-23-000052.md) | [7,836](/filings/0000749251-25-000008.md) | [7,710](/filings/0000749251-24-000024.md) | [7,431](/filings/0000749251-24-000035.md) | [7,845](/filings/0000749251-24-000041.md) | [8,535](/filings/0000749251-26-000112.md) | [8,480](/filings/0000749251-25-000028.md) | [8,328](/filings/0000749251-25-000046.md) | [7,249](/filings/0000749251-25-000082.md) | [8,085](/filings/0000749251-26-000245.md) | [7,655](/filings/0000749251-26-000167.md) | [7,194](/filings/0000749251-26-000245.md) |
| Current liabilities | $m | [3,313](/filings/0000749251-23-000052.md) | [3,778](/filings/0000749251-25-000008.md) | [3,640](/filings/0000749251-24-000024.md) | [3,462](/filings/0000749251-24-000035.md) | [3,472](/filings/0000749251-24-000041.md) | [3,969](/filings/0000749251-26-000112.md) | [3,792](/filings/0000749251-25-000028.md) | [3,594](/filings/0000749251-25-000046.md) | [3,490](/filings/0000749251-25-000082.md) | [4,072](/filings/0000749251-26-000245.md) | [3,886](/filings/0000749251-26-000167.md) | [3,663](/filings/0000749251-26-000245.md) |
| Total liabilities | $m | [6,678](/filings/0000749251-23-000052.md) | [7,155](/filings/0000749251-25-000008.md) | [6,992](/filings/0000749251-24-000024.md) | [6,784](/filings/0000749251-24-000035.md) | [6,781](/filings/0000749251-24-000041.md) | [7,176](/filings/0000749251-26-000112.md) | [6,982](/filings/0000749251-25-000028.md) | [6,795](/filings/0000749251-25-000046.md) | [6,693](/filings/0000749251-25-000082.md) | [7,765](/filings/0000749251-26-000245.md) | [7,592](/filings/0000749251-26-000167.md) | [7,361](/filings/0000749251-26-000245.md) |
| Long-term debt | $m | [2,450](/filings/0000749251-23-000052.md) | [2,449](/filings/0000749251-25-000008.md) | [2,457](/filings/0000749251-24-000024.md) | [2,458](/filings/0000749251-24-000035.md) | [2,459](/filings/0000749251-24-000041.md) | [2,460](/filings/0000749251-26-000112.md) | [2,461](/filings/0000749251-25-000028.md) | [2,462](/filings/0000749251-25-000046.md) | [2,462](/filings/0000749251-25-000082.md) | [2,977](/filings/0000749251-26-000245.md) | [2,978](/filings/0000749251-26-000167.md) | [2,979](/filings/0000749251-26-000245.md) |
| Current portion of debt | $m | [9.6](/filings/0000749251-23-000052.md) | [9.6](/filings/0000749251-25-000008.md) | [0.0](/filings/0000749251-24-000024.md) | [0.0](/filings/0000749251-24-000035.md) | [0.0](/filings/0000749251-24-000041.md) | [0.0](/filings/0000749251-26-000112.md) | not reported | [0.4](/filings/0000749251-25-000046.md) | [0.7](/filings/0000749251-25-000082.md) | [5.0](/filings/0000749251-26-000245.md) | [5.0](/filings/0000749251-26-000167.md) | [0.0](/filings/0000749251-26-000245.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [567](/filings/0000749251-24-000041.md) | [681](/filings/0000749251-26-000112.md) | [718](/filings/0000749251-25-000082.md) | [647](/filings/0000749251-25-000082.md) | [1,065](/filings/0000749251-25-000082.md) | [1,359](/filings/0000749251-26-000245.md) | [1,498](/filings/0000749251-26-000245.md) | [1,533](/filings/0000749251-26-000245.md) | [557](/filings/0000749251-25-000082.md) | [320](/filings/0000749251-26-000245.md) | [63.4](/filings/0000749251-26-000245.md) | [(167)](/filings/0000749251-26-000245.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [331 d](/filings/0000749251-24-000041.md) | [224 d](/filings/0000749251-26-000112.md) | [189](/filings/0000749251-25-000028.md) | [370 d](/filings/0000749251-25-000046.md) | [591 d](/filings/0000749251-25-000082.md) | [335 d](/filings/0000749251-26-000112.md) | [314](/filings/0000749251-26-000167.md) | [384 d](/filings/0000749251-26-000245.md) | [299 d](/filings/0000749251-25-000082.md) | [295 d](/filings/0000749251-26-000112.md) | [391](/filings/0000749251-26-000167.md) | [398 d](/filings/0000749251-26-000245.md) |
| Share repurchases | $m | [209](/filings/0000749251-24-000041.md) | [158 d](/filings/0000749251-26-000112.md) | [225](/filings/0000749251-25-000028.md) | [340](/filings/0000749251-25-000046.md) | [68.7](/filings/0000749251-25-000082.md) | [102 d](/filings/0000749251-26-000112.md) | [163](/filings/0000749251-26-000167.md) | [274](/filings/0000749251-26-000245.md) | [1,056](/filings/0000749251-25-000082.md) | [498 d](/filings/0000749251-26-000112.md) | [535](/filings/0000749251-26-000167.md) | [547](/filings/0000749251-26-000245.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [80.1](/filings/0000749251-23-000052.md) | [80.3](/filings/0000749251-24-000024.md) | [79.8](/filings/0000749251-24-000035.md) | [79.5](/filings/0000749251-24-000041.md) | [79.0](/filings/0000749251-25-000028.md) | [78.3](/filings/0000749251-25-000046.md) | [78.0](/filings/0000749251-25-000082.md) | [77.8](/filings/0000749251-26-000167.md) | [77.4](/filings/0000749251-26-000245.md) | [75.0](/filings/0000749251-25-000082.md) | [70.0](/filings/0000749251-26-000167.md) | [66.6](/filings/0000749251-26-000245.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 63,148,976 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000749251-26-000245.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.
